Objective:
To describe variation in morphology, immunohistochemical findings, and clinical course in two patients with pulmonary NUT carcinoma.
Approach:
- Cases: The authors reviewed tumor morphology, squamous differentiation, immunostaining, treatment, disease progression, and survival in two patients.
- Diagnostic assessment: Testing included NUT, AE1/AE3, CAM5.2, p63, and p40 immunostaining, as well as Ki-67 labeling.
Key Findings:
- One tumor showed prominent squamous differentiation and AE1/AE3 and CAM5.2 positivity; the other had only small foci of squamous differentiation, limited AE1/AE3 staining, and negative CAM5.2 staining.
- Both tumors were positive for p63, p40, and NUT. Ki-67 labeling indices were approximately 30% and 50%.
- Both patients developed aggressive disease progression and died: one 5 months after admission and the other 1 year after surgery.
- The authors cited prior analyses reporting squamous differentiation in 33% of 124 NUT carcinoma cases and absent keratin expression in approximately 20%.
Interpretation:
The authors stated that inconspicuous squamous differentiation or negative keratin staining does not exclude pulmonary NUT carcinoma; diagnosis relies on positive NUT protein immunohistochemistry or molecular testing.
Limitations:
- The report included only two patients and was descriptive, so it cannot establish how frequently these features occur.
- Differences in tissue sampling and retrospective confirmation of the first diagnosis complicated direct comparison.
Conclusion:
The authors reported no funding or conflicts of interest.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
